Prelude Therapeutics
Saishuai Wen is a Senior Research Scientist at Prelude Therapeutics, a role held since June 2021, following a position as a Research Scientist. Prior experience includes serving as a PhD Research Assistant at Boston University from September 2016 to May 2021 under the guidance of Dr. John A. Saishuai Wen earned a Doctor of Philosophy (PhD) in Organic Chemistry with a focus on Natural Product Synthesis from Boston University in 2021. Previous academic qualifications include a Master's degree in Organic Chemistry specializing in Enantioselective Organocatalysis from Central South University, completed in 2016, and a Bachelor's degree in Applied Chemistry from Central South University, obtained in 2013.
Prelude Therapeutics
3 followers
Prelude Therapeutics is a clinical-stage precision oncology company developing innovative drug candidates targeting critical cancer cell pathways.